Skip to main content

Table 1 The definition and incidence of adverse events

From: Efficacy and safety of remimazolam besylate versus propofol during hysteroscopy: single-centre randomized controlled trial

Adverse events

Definitions

Group R

(N = 41)

Group P

(n = 41)

p value

Injection pain

‘Subjective’ assessment, patients verbally reported their pain by themselves after the first injection

1 (2.4%)

33 (80.5%)

< 0.001

Low SpO2

Intraoperative SpO2 ≤ 95%

4 (9.8%)

21 (51.2%)

< 0.001

Bradycardia

Intraoperative HR < 55 bpm

0 (0.0%)

1 (2.4%)

0.314

Hypotension

Intraoperative SBP<90 mmHg

1 (2.4%)

5 (12.2%)

0.090

Total incidence of adverse events

 

6 (3.7%)

60 (36.6%)

< 0.001

Postoperative dizziness

Appeared while patients stayed in the postanaesthesia care unit (PACU)

0 (0.0%)

10 (24.4%)

< 0.001

Body movement

Visible hand bending or head movement

15 (36.6%)

20 (48.8%)

0.264

  1. Note: Values are presented as n (%); HR-heart rate; SBP-systolic blood pressure